CorMedix Inc. (CRMD) › Operating IncomeCorMedix Inc. (CRMD) — Operating IncomeAnnual figures by period end, from SEC filings.2010-12-31: -$8.51M2011-12-31: -$7.21M2012-12-31: -$3.00M2013-12-31: -$4.92M2014-12-31: -$8.90M2015-12-31: -$16.65M2016-12-31: -$24.76M2017-12-31: -$32.92M2018-12-31: -$26.86M2019-12-31: -$21.01M2020-12-31: -$27.22M2021-12-31: -$29.44M2022-12-31: -$30.62M2023-12-31: -$48.96M2024-12-31: -$22.36M2025-12-31: $150.14M$150.14M2010-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31$150.14M—2026-03-05From 2025-01-012024-12-31-$22.36M—2026-03-05From 2024-01-012023-12-31-$48.96M—2025-03-25From 2023-01-012022-12-31-$30.62M—2024-03-12From 2022-01-012021-12-31-$29.44M—2023-03-30From 2021-01-012020-12-31-$27.22M—2022-03-29From 2020-01-012019-12-31-$21.01M—2021-03-30From 2019-01-012018-12-31-$26.86M—2020-03-16From 2018-01-012017-12-31-$32.92M—2019-05-29From 2017-01-012016-12-31-$24.76M—2018-03-19From 2016-01-012015-12-31-$16.65M—2017-03-16From 2015-01-012014-12-31-$8.90M—2017-03-16From 2014-01-012013-12-31-$4.92M—2015-03-12From 2013-01-012012-12-31-$3.00M—2014-03-31From 2012-01-012011-12-31-$7.21M—2014-03-04From 2011-01-012010-12-31-$8.51M—2012-04-26From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)